AIC Phase II data for Dynavax

Dynavax (Berkeley, Calif.) reported that in a French Phase II trial of its AIC anti-allergy vaccine in 27 adults with ragweed allergies, a six-injection dose-ranging regimen was safe and well-tolerate...